Connors Investor Services Inc Abbott Laboratories Transaction History

Connors Investor Services Inc

  • $1.03 Billion
  • Q3 2024

A detailed history of Connors Investor Services Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Connors Investor Services Inc holds 160,485 shares of ABT stock, worth $18 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares
160,485
Previous 165,121 2.81%
Holding current value
$18 Million
Previous $17.2 Million 6.64%
% of portfolio
1.77%
Previous 1.79%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$100.07 - $118.13 $463,924 - $547,650
-4,636 Reduced 2.81%
160,485 $18.3 Million
Q2 2024

Aug 09, 2024
SELL
$100.73 - $112.44 $518,356 - $578,616
-5,146 Reduced 3.02%
165,121 $17.2 Million
Q1 2024

May 10, 2024
SELL
$109.52 - $120.96 $165,265 - $182,528
-1,509 Reduced 0.88%
170,267 $19.4 Million
Q4 2023

Feb 14, 2024
SELL
$90.19 - $110.4 $10,912 - $13,358
-121 Reduced 0.07%
171,776 $18.9 Million
Q3 2023

Nov 22, 2023
SELL
$95.53 - $114.62 $96,771 - $116,110
-1,013 Reduced 0.59%
171,897 $16.6 Million
Q2 2023

Aug 14, 2023
SELL
$100.78 - $112.29 $166,085 - $185,053
-1,648 Reduced 0.94%
172,910 $18.9 Million
Q1 2023

May 15, 2023
BUY
$96.86 - $114.01 $20,534 - $24,170
212 Added 0.12%
174,558 $17.7 Million
Q4 2022

Feb 15, 2023
SELL
$95.06 - $111.52 $145,346 - $170,514
-1,529 Reduced 0.87%
174,346 $19.1 Million
Q3 2022

Nov 14, 2022
BUY
$96.76 - $112.03 $211,614 - $245,009
2,187 Added 1.26%
175,875 $17 Million
Q2 2022

Aug 16, 2022
SELL
$102.07 - $123.37 $191,381 - $231,318
-1,875 Reduced 1.07%
173,688 $18.9 Million
Q1 2022

May 18, 2022
BUY
$114.02 - $139.04 $266,806 - $325,353
2,340 Added 1.35%
175,563 $20.8 Million
Q4 2021

Feb 15, 2022
BUY
$115.53 - $141.46 $521,617 - $638,691
4,515 Added 2.68%
173,223 $24.3 Million
Q3 2021

Nov 15, 2021
SELL
$116.66 - $129.06 $1.13 Million - $1.25 Million
-9,713 Reduced 5.44%
168,708 $19.9 Million
Q2 2021

Aug 10, 2021
SELL
$105.79 - $124.53 $417,976 - $492,018
-3,951 Reduced 2.17%
178,421 $20.7 Million
Q1 2021

Sep 15, 2021
BUY
$108.84 - $128.23 $308,561 - $363,532
2,835 Added 1.58%
182,372 $21.9 Million
Q4 2020

Feb 16, 2021
SELL
$105.0 - $114.42 $2.73 Million - $2.98 Million
-26,020 Reduced 12.66%
179,537 $19.7 Million
Q3 2020

Nov 16, 2020
SELL
$91.64 - $111.29 $737,427 - $895,550
-8,047 Reduced 3.77%
205,557 $22.4 Million
Q2 2020

Aug 14, 2020
SELL
$76.57 - $98.0 $1.18 Million - $1.51 Million
-15,441 Reduced 6.74%
213,604 $19.5 Million
Q1 2020

May 14, 2020
BUY
$62.82 - $91.86 $251,028 - $367,072
3,996 Added 1.78%
229,045 $18.1 Million
Q4 2019

Feb 14, 2020
BUY
$78.51 - $87.4 $1.32 Million - $1.47 Million
16,831 Added 8.08%
225,049 $19.5 Million
Q3 2019

Oct 28, 2019
SELL
$81.84 - $88.74 $409,691 - $444,232
-5,006 Reduced 2.35%
208,218 $17.4 Million
Q2 2019

Aug 14, 2019
SELL
$72.88 - $85.0 $37,751 - $44,030
-518 Reduced 0.24%
213,224 $17.9 Million
Q1 2019

May 10, 2019
SELL
$66.22 - $80.06 $250,179 - $302,466
-3,778 Reduced 1.74%
213,742 $17.1 Million
Q4 2018

Feb 13, 2019
BUY
$65.56 - $74.27 $125,219 - $141,855
1,910 Added 0.89%
217,520 $15.7 Million
Q3 2018

Nov 13, 2018
BUY
$60.81 - $73.36 $688,247 - $830,288
11,318 Added 5.54%
215,610 $15.8 Million
Q2 2018

Aug 13, 2018
BUY
$57.57 - $63.54 $39,090 - $43,143
679 Added 0.33%
204,292 $12.5 Million
Q1 2018

May 10, 2018
SELL
$56.27 - $63.62 $151,141 - $170,883
-2,686 Reduced 1.3%
203,613 $12.2 Million
Q4 2017

Feb 13, 2018
BUY
$53.68 - $57.47 $614,045 - $657,399
11,439 Added 5.87%
206,299 $11.8 Million
Q3 2017

Nov 13, 2017
BUY
$48.06 - $53.64 $9.36 Million - $10.5 Million
194,860
194,860 $10.4 Million

Others Institutions Holding ABT

# of Institutions
3,189
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Connors Investor Services Inc Portfolio

Follow Connors Investor Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connors Investor Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Connors Investor Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email